Andreas Struengmann Net Worth

Andreas Struengmann was born in Tegernsee, Germany, Germany. In 2005, Andreas Struengmann and his twin brother, Thomas, who together founded generic drug maker Hexal AG in 1986, sold the business (along with their 68% stake in U.S.-based Eon Labs) to Novartis for $7.5 billion. Since then, they've been actively investing in biotechnology and pharmaceutical companies. Their holdings also include a private bank, Stuttgart-based Sudwestbank. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann. After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa. He is known to love sailing, golf and skiing.
Andreas Struengmann is a member of Health care

Age, Biography and Wiki

Birth Place Tegernsee, Germany, Germany

💰 Net worth: $21.1 Billion (2022)

2009 $3.6 Billion
2010 $3.8 Billion
2011 $3.9 Billion
2012 $3.3 Billion
2013 $3.4 Billion
2014 $3.5 Billion
2015 $3.3 Billion
2016 $3.2 Billion
2017 $3.1 Billion
2018 $3.72 Billion